The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...
(Reuters) -Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, ...
More than two decades since the launch of global programs dedicated to bringing prevention, diagnostic, and treatment services to people at risk of, or living with, human immunodeficiency virus (HIV), ...
Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades, and provided life-saving medicines for ...
The United States has suspended some funding for its flagship AIDS relief program, according to international organizations and members of Congress who warn the cuts are already hurting patients and ...
The Global Fund was established in 2002 to support preventing and treating HIV, Tuberculosis (TB), and malaria. The program brings together government, civil society, health workers, and the private ...
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
Gilead to supply lenacapavir at cost to 2 million people over three years Global Fund prioritizes access based on HIV incidence, focuses on sub-Saharan Africa Gilead CEO hopeful of future US funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback